ANDA 217399

MSN

FDA Drug Application

Application #217399

Application Sponsors

ANDA 217399

MSN

Marketing Status

• Prescription: 001
• Prescription: 002
• Prescription: 003

Application Products

001	TABLET;ORAL	5MG	0	OLMESARTAN MEDOXOMIL	OLMESARTAN MEDOXOMIL
002	TABLET;ORAL	20MG	0	OLMESARTAN MEDOXOMIL	OLMESARTAN MEDOXOMIL
003	TABLET;ORAL	40MG	0	OLMESARTAN MEDOXOMIL	OLMESARTAN MEDOXOMIL

FDA Submissions

UNKNOWN;

ORIG

1

AP

2023-01-18

STANDARD

Submissions Property Types

ORIG

1

Null

7

TE Codes

001	Prescription	AB
002	Prescription	AB
003	Prescription	AB

CDER Filings

MSN

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 217399
            [companyName] => MSN
            [docInserts] => ["",""]
            [products] => [{"drugName":"OLMESARTAN MEDOXOMIL","activeIngredients":"OLMESARTAN MEDOXOMIL","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"OLMESARTAN MEDOXOMIL","activeIngredients":"OLMESARTAN MEDOXOMIL","strength":"20MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"OLMESARTAN MEDOXOMIL","activeIngredients":"OLMESARTAN MEDOXOMIL","strength":"40MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/18\/2023","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2023-01-18
        )

)